Statin Prevents AF After OPCAB emergency operation, 30 patients who had chronic AF, and 6 patients who underwent revascularization using cardiopulmonary bypass. The remaining 584 patients were retrospectively reviewed. Of this cohort, 364 patients received statin (146 atorvastatin, 77 pitavastatin, 62 pravastatin, 35 rosuvastatin, 25 simvastatin, and 19 fluvastatin) daily for at least 5 days before operation. The remaining 220 patients received no statin.
Propensity score was created to quantify the likelihood that a given patient would receive statin therapy. Univariate analysis was performed to examine differences in preoperative characteristics between patients on statin (n=364) and patients not on statin (n=220; Table 1) . Propensity scores were then calculated using a multivariate logistic regression model based on the following 8 preoperative characteristics with a significance level of P<0.25 on univariate analysis: age, female, body mass index, creatinine, diabetes mellitus, history of myocardial infarction, New York Heart Association class, and ejection fraction. 16 The area under the receiver operating characteristic curve for this model was 0.69 (95% confidence interval [95%CI]=0.65-0.74). Patients on statin had a significantly higher mean propensity score than those not on statin (0.635±0.079 vs 0.605±0.088; P=0.01). There was considerable overlap in the propensity scores of patients on statin (interquartile range [IQR]=0.585-0.685; minimum, 0.411, maximum, 0.766) and patients not on statin (IQR= 0.556-0.672; minimum, 0.340, maximum, 0.781). Each patient on statin was matched with a patient not on statin with the closest propensity score (within 0.030 on a scale of 0-1). By matching propensity scores, 195 pairs were successfully matched in a 1:1 manner (statin group, n=195; no statin group, n=195).
The endpoint was new-onset AF after operation. AF was diagnosed by the physicians when there was an irregular cardiac rhythm without P-waves lasting >30 min on 12-lead electrocardiogram.
Preoperative Medication
All patients were admitted to hospital at least 5 days before operation. Basically, we did not alter the medications prescribed by the cardiologists who referred the patients to us, even if statin or β-blockers were not included. Except for anti-platelet and anticoagulant drugs, preoperative medications were continued up to the day of the operation. Anti- 
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platelet and anticoagulant drugs were discontinued at least 5 days before operation and iv administration of heparin was continued until 6 h before operation for unstable patients with critical stenoses.
Anesthetic Technique
The induction of anesthesia was achieved with iv administration of fentanyl citrate (5-10 μg/kg), midazolam (0.15-0.3 mg/kg), and vecronium bromide (0.1 mg/kg). Anesthesia was maintained with iv administration of fentanyl and propofol (2-3 mg/kg) and inhalation administration of low concentrations of sevoflene (<4%) as necessary. Anticoagulation was achieved with heparin (1 mg/kg) after the conduits were harvested. The activated clotting time was maintained at >250 s.
Surgical Technique
The off-pump technique was used for all patients. After a median full sternotomy, the internal thoracic artery and gastroepiploic artery were harvested with a skeletonization technique using an ultrasonic scalpel (Harmonic Scalpel, Ethicon Endo-Surgery, Cincinnati, OH, USA) in all cases. 17-20 A few superficial and deep pericardial sutures were placed to facilitate cardiac displacement. During anastomosis, a suction-type mechanical stabilizer (Octopus 4.3, Medtronic, Minneapolis, MN, USA) was used to immobilize the target site of coronary artery. Distal myocardial perfusion was maintained using intracoronary shunt tube (Anastaflo, Edwards Lifescience, Irvine, CA, USA). The basic strategy for myocardial revascularization was in situ grafting of bilateral internal thoracic artery to the left coronary system with complementary saphenous vein and/or gastroepiploic artery. In the majority of cases, in situ right internal thoracic artery was tunneled through a right pericardial incision and routed anterior to the aorta across the midline for grafting to the left anterior descending artery, and in situ left internal thoracic artery was used for the diagonal branches and/or circumflex branches. The gastroepiploic artery was used as an in situ graft to revascularize the postero-inferior wall. In cases of less than critical coronary stenosis, however, saphenous vein was used.
Vein-to-aorta proximal anastomosis was performed using partial clamping or an anastomotic device. To prevent complications related to manipulation of the ascending aorta, we Statin Prevents AF After OPCAB routinely performed preoperative computed tomography and epi-aortic ultrasonography and assessed the severity and the location of atherosclerosis of the aorta. When the surgeon judged that partial clamping of the ascending aorta increased the risk of embolism, a proximal anastomotic device including the Enclose device (Novare Surgical Systems, Cupertino, CA, USA), the Heartstring Proximal Seal System (Guidant, Santa Clara, CA, USA), or the Symmetry Aortic Connector System, St Jude Medical, St Paul, MN, USA) was used. After completion of anastomoses, heparin was antagonized with protamine sulfate at a 1:1 ratio.
Postoperative Management
After operation, all patients had continuous electrocardiographic monitoring using a bedside monitor in the intensive care unit and telemetry on the hospital ward for at least 7 days. When episodes of arrhythmia were captured by an automatic alarm function, 12-lead electrocardiogram was performed and assessed by the physicians. Oral medications, including β-blocker, angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) were initiated when clinically indicated. At Shiga University of Medical Science the majority of patients were extubated on the day of surgery and the oral medications were initiated on postoperative day 1.
Blood glucose and potassium levels were obtained from arterial blood gas samples every 2-4 h in the intensive care unit and adjusted to target blood glucose between 100 and 200 mg/dl using continuous insulin infusion and blood potassium between 4.0 and 5.5 mmol/L using iv administration of potassium chloride. Once patients were transferred to the floor, blood glucose measurements were done every 4-6 h via finger stick blood samples and maintained according to the sliding scale with subcutaneous insulin in addition to their preoperative subcutaneous regimens. Blood potassium levels were checked every morning and adjusted with oral potassium chloride.
Statistical Analysis
Categorical data are summarized using absolute values (percentage) and compared using Pearson chi-square test. Normally distributed continuous data are presented as mean ± SD and compared using Student's t-test or, where skewed, as median (IQR) and compared using Mann -Whitney U-test. Logistic regression model was used for estimating odds ratio (OR) and 95%CI. Each variable of baseline characteristics and operative data was entered into the univariate logistic regression model. All variables statistically significant on the univariate model were then entered into a multivariate model with backward elimination (P<0.05 for retention). The significant level of P was set at 5%. All statistical analyses were performed with SPSS version 11.0 (SPSS, Chicago, IL, USA).
Results
In the original cohort, the incidence of postoperative AF was 13.7% (50/364) in the statin group and 24.5% (54/220) in the no statin group (P=0.01).
There was no significant difference between the propensity score-matched groups in baseline characteristics, preoperative medications, and operative data (Tables 2,3) . 
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The rate of postoperative AF was significantly lower in the statin group than the no statin group (14.4% vs 24.6%, P=0.01). The mean time to AF occurrence was 2.09±0.65 days in the statin group and 2.12±0.73 days in the no statin group (P=0.64). Postoperative AF occurred most often (33%) on postoperative day 2, with 82% occurrences on postoperative days 1, 2, or 3. There was no significant difference between the groups in postoperative hospital stay. The patients with postoperative AF, however, had a significantly longer median postoperative hospital stay than those without AF (15 days, range =12-19 days, vs 13 days, range =10-15 days, P=0.02). The 30-day mortality rate was 1.0% (2/195) in the statin group and 0.5% (1/195) Postoperative serum potassium and C-reactive protein (CRP) levels tended to be lower in the statin group than in the no statin group, but the difference was not statistically significant ( 
Discussion
In this analysis of a propensity score-matched cohort of 390 Japanese patients undergoing elective isolated off-pump CABG, the rate of postoperative AF in patients receiving preoperative statin was significantly lower than in patients without statin therapy; multivariate analysis identified preoperative statin as an independent factor associated with a significant reduction in postoperative AF.
A recent meta-analysis of 17,643 patients with or without statin use before cardiac surgery demonstrated that pretreatment with statin resulted in a significantly lower incidence of postoperative AF when compared with control (28.2% vs 32.2%, P=0.0001), therefore preoperative statin was protective against developing postoperative AF (OR=0.66; 95%CI = 0.48-0.89; P=0.0070). 21 In this meta-analysis the majority of patients (97.7%, 17,002 patients) underwent surgery with cardiopulmonary bypass. Song et al investigated the preventive effects of atorvastatin on the incidence of AF after elective off-pump coronary artery bypass surgery. 13 In that study the rate of postoperative AF in the atorvastatin group was significantly lower than in the control group (13% vs 27%, P=0.04), and multivariate analysis identified pretreatment with atorvastatin as an independent factor associated with a significant reduction in postoperative AF (OR=0.34; 95%CI = 0.12-0.93; P=0.04). The present results are in close agreement with those studies.
Statins were reported to have some pharmacological effects beyond their primary lipid-lowing action, including an antiinflammatory effect. 22 In a recent prospective randomized trial by Ji et al, preoperative atorvastatin significantly decreased the rates of AF following off-pump CABG (14% vs 34%; OR =0.219; 95%CI =0.076-0.633; P=0.005). 14 In addition, they demonstrated that the postoperative mean peak CRP level in the statin group was significantly lower than that in the control group, and postoperative CRP above the median was an independent risk factor of postoperative AF. In the present study the statin group tended to have a lower postoperative CRP level than the no statin group, but there was no statistical significance.
Selection and treatment bias are a major problem inherent in non-randomized studies. In the present study, in an attempt to minimize the potential bias, we included only patients who underwent elective isolated coronary bypass surgery without cardiopulmonary bypass. Moreover, we performed pair matching based on propensity score. As a result a total of 29 preoperative characteristics, including β-blocker, were similar for the 2 comparison groups (Tables 1, 2) .
There are several important limitations in this study. First, this is a retrospective study. Even if we performed propensity score matching and included only elective off-pump surgery, we could not eliminate residual unobserved confounding factors and cannot truly evaluate the effect of pretreatment with statin, as we could in a prospective randomized trial. Second, the present study population was small, resulting in insufficient statistical power. The limited number of events did not allow the construction of a statistical model to assess the impact of statin on other adverse events (30-day mortality, myocardial infarction, and stroke). Finally, there was no available information on history of paroxysmal AF before admission, which might have influenced occurrence of postoperative AF.
In conclusion, pretreatment with statin significantly reduces the incidence of AF after elective isolated off-pump CABG in Japanese patients.
